Asthma: all 4,012 studies
Page 30 of 41. Open to participants first (515), then studies with results posted, then the rest; newest registration first within each.
- A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)CompletedNCT01545440Phase 2
- Effects of Preventive Treatment for Respiratory Syncytial (RS) Virus Infection During Infancy on Later Atopic Asthma in Preterm InfantsCompletedNCT01545245
- Beta Blocker Therapy in Mild to Moderate AsthmaticsCompletedNCT01544634Phase 2
- Cell Distribution in Induced Sputum in Patients With AsthmaCompletedNCT01543516
- A Single Centre Study in Healthy Volunteers to Optimise the Rotacap Formulation and ROTAHALER Device for Delivery of Fluticasone Propionate/SalmeterolCompletedNCT01540708Phase 1
- Reflux Disease Therapy in the Management of Childhood Asthma-data Entry and Analysis OnlyCompletedNCT01536457
- A Placebo and Active Controlled Study of ONO-6950 in Asthmatic PatientsCompletedNCT01536041Phase 2
- Prospective Study of the Feedback From an Adherence Monitor on Asthma ControlCompletedNCT01529697Not applicable
- The Use of FKBP51 in the Identification of Non-adherence to Inhaled Corticosteroids in Difficult AsthmaCompletedNCT01526707Not applicable
- Management of Asthma in School-age Children on TherapyCompletedNCT01526161Phase 4
- Strategies to Improve Asthma and Treatment of Asthma in CanadiansCompletedNCT01525381
- An Electronic Decision Support Tool to Improve Outpatient Asthma CareCompletedNCT01522144Not applicable
- Pilot Study of Magnesium Infusions in Pediatric AsthmaWithdrawnNCT01522040Phase 2/3
- Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic PatientsCompletedNCT01521455Phase 1
- Implementation of a Pediatric-to-adult Asthma Transition ProgramCompletedNCT01521247Not applicable
- Evaluation of Decisional Conflict and Needs Assessment in Asthma ManagementCompletedNCT01520883
- Mepolizumab Treatment for Rhinovirus-induced Asthma ExacerbationsStatus unknownNCT01520051Phase 3
- A 12-Week Study in Adult Subjects With AsthmaCompletedNCT01516086Phase 2
- 12-Week Study in Adult Subjects With AsthmaCompletedNCT01516073Phase 2
- AMG 761 in Adults With AsthmaTerminatedNCT01514981Phase 1
- Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric PatientsCompletedNCT01511367Phase 3
- Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate AsthmaCompletedNCT01511302Phase 1
- Breathing & Mild Physical Exercise Therapy for AsthmaCompletedNCT01509443Not applicable
- Characterization of Adult Subjects for Asthmatic Research StudiesSuspendedNCT01508078
- Effect of a Component of Fish Oil on Exercise-Induced Bronchoconstriction and Airway Inflammation in AsthmaCompletedNCT01504646Not applicable
- Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic AsthmaCompletedNCT01501942Phase 2
- A Study of GW685698X 100mcg Administered Once Daily Either in the Morning or the Evening and GW685698X 250mcg Administered Once Daily in the Evening Via DISKHALER for 28 Days in Subjects With Persistent Bronchial Asthma.CompletedNCT01499446Phase 2
- Noninvasive Positive Airway Pressure in the Pediatric Emergency Department for the Treatment of Acute Asthma ExacerbationsWithdrawnNCT01497691Not applicable
- Study of JNJ-39758979 in Symptomatic Adult Patients With Uncontrolled AsthmaWithdrawnNCT01493882Phase 2
- Comparison of Two Treatment Regimens in Asthmatic PatientsCompletedNCT01488773
- Single Dose Study of the Fluticasone/Salmeterol (500/50 μg) Administered With Elpenhaler® Versus Diskus®CompletedNCT01484210Phase 3
- Effect of Ectoin® Inhalation Solution on Subjects With Mild Bronchial AsthmaCompletedNCT01478152Not applicable
- Safety Study in Adolescent and Adult Patients With AsthmaCompletedNCT01476904Phase 3
- Pediatric Study to Evaluate Treatment of Persistent Moderate or Severe Asthma With the Association Fluticasone 250 mcg/Dose and Salmeterol 50 mcg/Dose - ADERE PROJECTCompletedNCT01476059Phase 4
- ANASA (Patients' Satisfaction With Pulmonary Diseases' Treatment)CompletedNCT01475045
- Efficacy Study of the Product "CHF 1535" Versus Beclomethasone (BDP) and Free Combo in Asthmatic ChildrenCompletedNCT01475032Phase 3
- Asthma and Health Literacy in Newcomer Communities in the Greater Vancouver AreaCompletedNCT01474928Not applicable
- Treatment of IgE Associated Eczema With Omega-3 Long Chain Polyunsaturated Fatty Acids in Infancy and the Development of Bronchial Asthma in ChildhoodStatus unknownNCT01473823Not applicable
- Urinary 8-isoprostane is Elevated in Acute Childhood AsthmaCompletedNCT01472471
- GSK2190915 Neutrophilic Asthma StudyCompletedNCT01471665Phase 2
- Safety, Tolerability, and Pharmacokinetics of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male SubjectsCompletedNCT01470911Phase 1
- Childhood Asthma Reduction StudyWithdrawnNCT01468805Not applicable
- Clinical Pharmacology of CHF 1535 50/6 ug Next DPI in Children 5-11 Years OldCompletedNCT01468272Phase 2
- E-support for Healthcare Processes - ASTHMACompletedNCT01461642Not applicable
- Impact of Omalizumab on Corticosteroid Use, Emergency Room Visits and HospitalizationsWithdrawnNCT01460862
- Evaluation of Efficacy and Safety of E004 in Children With AsthmaCompletedNCT01460511Phase 3
- Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled CorticosteroidsWithdrawnNCT01458912Phase 2
- Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Short Acting Beta-2 Agonist (SABA) Therapy AloneWithdrawnNCT01458886Phase 2
- Fine Particle pMDI Formoterol/Beclomethasone in Asthmatics With and Without Spacer: Comparative Efficacy EvaluationCompletedNCT01453881Phase 3
- Effect of Home Health Case Management on Asthma MorbidityWithdrawnNCT01451944Not applicable
- Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Assessed by Knemometry and Urinary Cortisol Measurements in Asthmatic ChildrenCompletedNCT01450774Phase 3
- Predictors of Asthma Exacerbations in ChildrenCompletedNCT01449435
- Reduce IDentified UNcontrolled AsthmaActive, not recruitingNCT01449409Not applicable
- Masitinib in Treatment of Patients With Severe Persistent Asthma Treated With Oral CorticosteroidsCompletedNCT01449162Phase 3
- Mannitol Challenge Test in Adult Asthma Patients With Fixed Dose CombinationsCompletedNCT01449123Phase 4
- A Study to Evaluate Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic AsthmaCompletedNCT01448954Phase 2
- Effects of Educational Intervention on Long-Term Outcomes of Hospitalized Children With AsthmaCompletedNCT01447459Not applicable
- Vitamin and Asthma StudyCompletedNCT01447173Phase 4
- Assessing Decision Maker Tools for Asthma: the Asthma APGARStatus unknownNCT01446315Phase 4
- Stress Management Intervention in Inner City Adolescents With AsthmaStatus unknownNCT01445015Phase 2
- AZithromycin Against pLacebo in Exacerbations of AsthmaCompletedNCT01444469Phase 4
- Metabolomic Analysis of Exhaled Breath Condensate in AsthmaticsStatus unknownNCT01439737
- Observational Study on Efficacy of Alvesco(Ciclesonide) in Asthma Children and Adolescent in Real PracticeCompletedNCT01438255
- Dose Finding Study for QAW039 in AsthmaCompletedNCT01437735Phase 2
- A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent AsthmaCompletedNCT01436890Phase 2
- A Study of a New Asthma Medicine in Asthmatics Whose Asthma Worsens With ExerciseWithdrawnNCT01435902Phase 3
- House Dust Mite Treatment of Asthma. The MITRA Trial House Dust Mite Treatment of AsthmaCompletedNCT01433523Phase 3
- Observed Outcomes Associated With Fluticasone Propionate/Salmeterol Xinafoate or Inhaled Corticosteroids in Asthma PatientsCompletedNCT01431924
- Magnesium Nebulization Utilization in Management of Pediatric AsthmaCompletedNCT01429415Phase 2
- Olodaterol Bridging Study in AsthmaWithdrawnNCT01428622Phase 2
- Observational Study to Evaluate the Correctness of the Use of Inhaler Device in Patients With Asthma or Chronic ObstructCompletedNCT01426893
- Clinical Effect of Reflexology and Homeopathy Added to Conventional Asthma ManagementCompletedNCT01426061Not applicable
- Respiratory Outcome at Adolescence of Very Low Birthweight InfantsCompletedNCT01424553Not applicable
- Single Dose Study of GSK1440115 in Patients With AsthmaCompletedNCT01424280Phase 1
- Inspiratory Flow Parameters of Easyhaler and Diskus Inhalers (SALIF)CompletedNCT01424137Not applicable
- Safety and Efficacy of YHD001 in AsthmaCompletedNCT01424124Phase 2
- Personalized Asthma Care TeamCompletedNCT01423461
- Phase I Pharmacokinetic Study (BF-BLOCK)CompletedNCT01423305Phase 1
- Bacille Calmette-Guérin (BCG) Vaccine and AtopyCompletedNCT01420705
- Is a Diet Necessary When Corticosteroid Treatment is Prescribed?CompletedNCT01420133Not applicable
- Kinetics of IgE Memory B Cells, Plasmablasts and Plasma Cells After Whole Lung Allergen Challenge in Mild AsthmaticsCompletedNCT01420003Not applicable
- Leukotriene D4 Bronchial Provocation Test (LTD4-BPT) as an Indicator for the Use of Leukotriene Receptor Antagonist (LTRA)CompletedNCT01414868Not applicable
- A Phase IIa Study of KHK4563CompletedNCT01412736Phase 2
- A Repeat Dose Study to Investigate the Interaction of GSK2190915 on the Pharmacokinetics of RosuvastatinCompletedNCT01411111Phase 1
- Improving Parent Understanding of Instructions About Asthma CareCompletedNCT01405625Not applicable
- Effects of Leukotriene Modulator Montelukast on Cough Variant AsthmaStatus unknownNCT01404013Phase 4
- Impact of Continuous Positive Airway Pressure on the Treatment of Acute Asthma ExacerbationCompletedNCT01403467Phase 4
- Qvar Versus Clenil, a General Practice Research Database StudyCompletedNCT01400217
- Agricultural Health Study Follow-upCompletedNCT01399411
- Retrospective Study for Description of The Use Of Omalizumab In Patients With Difficult To Control AsthmaStatus unknownNCT01397760
- Rapid vs Maintenance Vitamin D Supplementation in Deficient Children With Asthma to Prevent Exacerbations.CompletedNCT01395589Phase 1
- Safety, Tolerability, and Pharmacokinetics of AMG 827 in Adolescents With AsthmaWithdrawnNCT01395485Phase 1
- Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and AsthmaCompletedNCT01393340Phase 2
- A Study to Assess Safety and Efficacy of a Novel Treatment, Keratinocyte Growth Factor (KGF), in Asthmatic PatientsCompletedNCT01386151Phase 2
- Asthma Phenotypes in the Inner CityCompletedNCT01383941
- Intravenous Magnesium in Wheezy BronchitisCompletedNCT01383655Not applicable
- The Role of Epigenetics in Inner City AsthmaCompletedNCT01382836
- Motivational Intervention for AsthmaStatus unknownNCT01381159Not applicable
- A Single Blind Study to Evaluate the Safety, Tolerability and Explore the Efficacy of 8.0 mg ASM8 Inhaled Daily for 14 Days in Severe AsthmaWithdrawnNCT01380236Phase 2
- Ex Vivo Effect of Surfactant Protein D on Pulmonary Cells in Patients With Asthma and Pilot Study to Assess Local Inflammation Induced by Segmental Allergen Challenge by Magnetic Resonance ImagingCompletedNCT01378624Not applicable